These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P. Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128 [Abstract] [Full Text] [Related]
23. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Parkinson Study Group. Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852 [Abstract] [Full Text] [Related]
24. Ropinirole: a review of its use in the management of Parkinson's disease. Matheson AJ, Spencer CM. Drugs; 2000 Jul; 60(1):115-37. PubMed ID: 10929932 [Abstract] [Full Text] [Related]
25. High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study. Arnold G, Gasser T, Storch A, Lipp A, Kupsch A, Hundemer HP, Schwarz J. Arch Gerontol Geriatr; 2005 Jul; 41(3):239-53. PubMed ID: 16029905 [Abstract] [Full Text] [Related]
26. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life. Fasano A, Ricciardi L, Lena F, Bentivoglio AR, Modugno N. Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551 [Abstract] [Full Text] [Related]
33. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up]. Salazar Tortolero G, Wix Ramos R, Salazar Aladrén P, Jiménez León JC. Rev Neurol; 2002 Jul; 38(8):715-9. PubMed ID: 15122540 [Abstract] [Full Text] [Related]
34. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ. Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709 [Abstract] [Full Text] [Related]
35. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. N Engl J Med; 2000 May 18; 342(20):1484-91. PubMed ID: 10816186 [Abstract] [Full Text] [Related]
38. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, LeWitt P, Oertel W, Quinn N, Sethi K, Stocchi F. Mov Disord; 2005 Jun 18; 20(6):726-33. PubMed ID: 15719426 [Abstract] [Full Text] [Related]
39. Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study. Ziegler M, Castro-Caldas A, Del Signore S, Rascol O. Mov Disord; 2003 Apr 18; 18(4):418-25. PubMed ID: 12671949 [Abstract] [Full Text] [Related]